King of Prussia, PA, United States of America

Mouhamadou L Mbow

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mouhamadou L Mbow

Introduction

Mouhamadou L Mbow is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of Toll Like Receptor 3 (TLR3) antagonists. His work has led to advancements in understanding and manipulating immune responses.

Latest Patents

Mbow holds 2 patents that focus on innovative methods and uses of TLR3 antagonists. His latest patents include "Toll Like Receptor 3 antagonists, methods and uses," which disclose TLR3 antagonists, polynucleotides encoding TLR3 antagonists, and methods of making and using these compounds. Another significant patent is "Antibody reactive with human toll like receptor 3," which details TLR3 modulators, such as antibodies and polynucleotides encoding TLR3 antibodies or fragments thereof, along with methods of making and using these innovations.

Career Highlights

Throughout his career, Mbow has worked with various companies, including Centocor, Inc. His experience in the biotechnology sector has allowed him to contribute to groundbreaking research and development projects.

Collaborations

Mbow has collaborated with notable colleagues, including Karen Duffy and Roberta Lamb. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Mouhamadou L Mbow's contributions to biotechnology, particularly through his patents on TLR3 antagonists, highlight his role as a significant inventor in the field. His work continues to influence advancements in immune response modulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…